Genetic testing in Hungary

The goal is to offer the country’s eye doctors and other specialists the wide portfolio of Asper’s test. Currently working in close collaboration with Optovision Ltd. Asper Biotech has the goal of reaching the Hungarian eye doctors offering them diagnostics solutions that are enhanced by our partner’s advancing knowledge in eye disease genetics. Co-operation with internet medicine network and wide partner network enables to reach the goals quickly and efficiently bringing on stronger brand presence for Asper and a comprehensive medical product market for Optovision.

Optovision is widening its network of clinics and doctors over all medical areas that Asper’s tests cover.

Asper at ESHG 2010

Several new innovative genetic tests and services will be launched on the market this year. At the European Human Genetics Conference on 12-15 June 2010 in Gothenburg, Sweden Asper’s representatives will provide wider and more attractive products than ever before. We are glad to meet our partners and clients in Asper Biotech (#B218) and Genorama (#B134) boxes.

About Us

Neurogenetics Portfolio News

Myotonia Congenita tests were added into Asper Biogene’s Neurogenetics portfolio. Metabolic Myopathy and Rhabdomyolysis panel has also been modified. Neutropenia has received an update in Asper Biogene’s Hematology portfolio and Asper Biogene’s Oncology portfolio has received a new test in the form of Ovarian Cancer.

Asper cardiogenetics and neurogenetics update

There have been several updates among Asper Cardiogenetics and Neurogenetics.

Asper Immunogenetics portfolio news

We have a brand new portfolio!

Dysmorphology update

Asper Dysmorphology now offer panels for Joubert Syndrome, Ehler-Danlos Syndrome, Bardet-Biedli Syndrome and many more.

Mitochondrial Genome Sequencing

The Cardiogenetics, Metabolic Disorders, and Otogenetics panels now offer mitochondrial genome sequencing.